Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 4
Results: 6
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 285, doi. 10.1007/s40261-024-01353-3
- By:
- Publication type:
- Article
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 271, doi. 10.1007/s40261-024-01354-2
- By:
- Publication type:
- Article
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 261, doi. 10.1007/s40261-024-01352-4
- By:
- Publication type:
- Article
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 223, doi. 10.1007/s40261-024-01351-5
- By:
- Publication type:
- Article
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 251, doi. 10.1007/s40261-024-01347-1
- By:
- Publication type:
- Article
Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 289, doi. 10.1007/s40261-024-01350-6
- By:
- Publication type:
- Article